Work

In Vitro Activity of a Novel Small Molecule Cyclin Dependent Kinase Inhibitor, CYC202 (seliciclib or R-Roscovitine), in Multiple Myeloma (MM).

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.3359.3359

Authors: Noopur Raje, Shaji Kumar, Teru Hideshima, Kenji Ishitsuka, Aldo Roccaro, Hiroshi Yasui, Makoto Hamasaki, Norihiko Shiraishi, Dharminder Chauhan, Nikhil C. Munshi, Simon R. Green, Kenneth C. Anderson

Institutions: Harvard University, Dana-Farber Cancer Institute, Cyclacel Pharmaceuticals (United Kingdom)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2547767435

FWCI:

Cites:

Cited by:

Related to: 10